Positions

Selected Publications

Academic Article

Year Title Altmetric
2023 Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes 2023
2022 Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.  JAMA Oncology.  8:1816-1820. 2022
2022 Classical and non-classical phenotypes of Erdheim–Chester disease: Correlating clinical, radiographic and genotypic findings.  British Journal of Haematology.  199:454-457. 2022
2022 Prolonged remission with pembrolizumab and radiation therapy in a patient with multisystem Langerhans cell sarcoma.  The hematology journal : the official journal of the European Haematology Association / EHA.  107:2276-2279. 2022
2022 Aberrant expression of lymphoid enhancer–binding factor 1 in Hodgkin lymphoma.  Human Pathology.  125:2-10. 2022
2022 Thinking Beyond the Marrow: Deceptive Presentation of a Rare Malignant Neoplasm.  Mayo Clinic Proceedings.  97:1337-1338. 2022
2022 Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.  Blood Cancer Journal.  12. 2022
2022 Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis.  Blood Cancer Journal.  12. 2022
2022 Histiocyte-rich pseudotumor — a post-chemotherapy radiologic dilemma.  Journal of Hematopathology.  15:45-46. 2022
2022 Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim–Chester disease.  American Journal of Hematology.  97:293-302. 2022
2022 Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience 2022
2022 Mimics of Erdheim–Chester disease.  British Journal of Haematology.  196:984-994. 2022
2021 Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival.  American Journal of Hematology.  96:1604-1610. 2021
2021 Dual Primary IGH Translocations in Multiple Myeloma: A Novel Finding.  Clinical Lymphoma, Myeloma and Leukemia.  21:e710-e713. 2021
2021 The significance of gradient expression of chromosome region maintenance protein 1 in large cell lymphoma.  The hematology journal : the official journal of the European Haematology Association / EHA.  106:2261-2264. 2021
2021 Metastatic Thyroid Carcinoma in Bone: A Different Disease than Expected in an Elderly Male With Known Adenocarcinoma of Prostate.  Mayo Clinic Proceedings.  96:1670-1671. 2021
2021 Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.  American Journal of Hematology.  96:E146-E150. 2021
2021 Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.  American Journal of Surgical Pathology.  45:550-557. 2021
2021 In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes.  Journal of the American Society of Nephrology.  32:695-706. 2021
2021 Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.  Blood.  137:513-523. 2021
2021 Rosai-dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2.  American Journal of Surgical Pathology.  45:35-44. 2021
2020 Efficacy of BRAF-Inhibitor Therapy in BRAFV600E-Mutated Adult Langerhans Cell Histiocytosis 2020
2020 Semaphorin 3B–associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients.  Kidney International.  98:1253-1264. 2020
2020 Standardized reporting of monoclonal immunoglobulin–associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group.  Kidney International.  98:310-313. 2020
2020 Hapticophagia: Tactile chew cravings in iron deficiency anemia.  American Journal of Hematology.  95:E107-E108. 2020
2020 Monoclonal Gammopathy of Undetermined Significance: Indications for Prediagnostic Testing, Subsequent Diagnoses, and Follow-up Practice at Mayo Clinic.  Mayo Clinic Proceedings.  95:944-954. 2020
2020 Proteomic Analysis of Complement Proteins in Membranous Nephropathy.  Kidney International Reports.  5:618-626. 2020
2020 Bone marrow findings in Erdheim-Chester disease: Increased prevalence of chronic myeloid neoplasms.  The hematology journal : the official journal of the European Haematology Association / EHA.  105:84-86. 2020
2020 Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.  The hematology journal : the official journal of the European Haematology Association / EHA.  105:348-357. 2020
2020 Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.  Kidney International.  97:163-174. 2020
2020 The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm.  Blood Cancer Journal.  10. 2020
2019 Concomitant Erdheim-Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin.  British Journal of Haematology.  187:e51-e54. 2019
2019 The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.  Mayo Clinic Proceedings.  94:2054-2071. 2019
2019 Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort.  Nephrology Dialysis Transplantation.  34:1508-1517. 2019
2019 Etiologies of Extreme Thrombocytosis: A Contemporary Series.  Mayo Clinic Proceedings.  94:1542-1550. 2019
2019 Patterns and utility of vitamin B12 and folate testing in patients with isolated thrombocytopenia.  Annals of Hematology.  98:1993-1994. 2019
2019 Exostosin 1/exostosin 2–associated membranous nephropathy.  Journal of the American Society of Nephrology.  30:1123-1136. 2019
2019 Karyomegalic interstitial nephritis in a renal allograft.  American Journal of Transplantation.  19:285-290. 2019
2018 The authors reply.  Kidney International.  94:632-633. 2018
2018 BK nephropathy with glomerular involvement.  Kidney International.  94:432. 2018
2018 C3 Glomerulopathy: Ten Years’ Experience at Mayo Clinic.  Mayo Clinic Proceedings.  93:991-1008. 2018
2018 Florid dermatopathic lymphadenopathy—A morphological mimic of Langerhans cell histiocytosis.  Clinical Case Reports.  6:1637-1638. 2018
2018 C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.  Kidney International.  94:178-186. 2018
2018 Evaluation of thrombocytopenia in the hematology clinic: A case series from a large tertiary care center.  Blood research.  53:166-167. 2018
2017 Pseudo-monoclonal gammopathy: A report of four cases.  The hematology journal : the official journal of the European Haematology Association / EHA.  102:e466-e469. 2017
2017 A follow-up on desiderosmia (olfactory craving), a novel symptom associated with iron deficiency anemia.  American Journal of Hematology.  92:E546. 2017
2017 C3 glomerulonephritis with a severe crescentic phenotype.  Pediatric Nephrology.  32:1625-1633. 2017
2017 High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.  American Journal of Hematology.  92:E164-E166. 2017
2017 The Authors Reply.  Kidney International.  92:517. 2017
2017 Desiderosmia (olfactory craving): A novel symptom associated with iron deficiency anemia.  American Journal of Hematology.  92:E93-E94. 2017
2017 Thrombotic microangiopathy associated with monoclonal gammopathy.  Kidney International.  91:691-698. 2017
2017 Estimating the annual volume of hematologic cancer cases per hematologist–oncologist in the United States: are we treating rare cancers too rarely? 2017
2016 Prevalence, incidence and survival of smoldering multiple myeloma in the United States.  Blood Cancer Journal.  6. 2016
2016 Polyclonal Localized Light Chain Amyloidosis—A Distinct Entity?.  Clinical Lymphoma, Myeloma and Leukemia.  16:588-592. 2016

Research Overview

  • Lymphomas
    Histiocytic Neoplasms (Erdheim-Chester Disease, Rosai Dorfman Disease, Langerhans Cell histiocytosis, Histiocytic Sarcoma. Langerhans cell sarcoma, etc.)

    • Education And Training

    Full Name

  • Aishwarya Ravindran